Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 17 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (8)
P 4 (1)

Trial Status

Recruiting8
Not Yet Recruiting5
Active Not Recruiting2
Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT07586995RecruitingPrimary

A Post-Market Assessment of the Safety and Performance of the TriClip™ System

NCT07454980Not ApplicableRecruitingPrimary

Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)

NCT07705594Not ApplicableActive Not RecruitingPrimary

LuX-Valve Plus System for Severe or Greater Tricuspid Regurgitation

NCT07668739Phase 4Not Yet Recruiting

Efficacy of Verciguat in TR and RV Failure

NCT07617974Recruiting

Natural History of Atrial Fibrillation-Induced Tricuspid Valve Remodeling in the Absence of Significant Tricuspid Regurgitation: A Three-Dimensional Echocardiographic Study

NCT07607093Recruiting

Efficacy of Early Rhythm Control in AF With TR Patients

NCT07578129Not Yet Recruiting

PASCAL Precision-GDMT Registry

NCT07528326Not ApplicableNot Yet RecruitingPrimary

The TRICURE US IDE Pivotal Study

NCT07197736Recruiting

DELINEATE-Prospective

NCT07500025Not Yet RecruitingPrimary

Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)

NCT06568003Not ApplicableActive Not RecruitingPrimary

TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (TRINITY-US)

NCT07263659Not ApplicableCompleted

Virtual Reality Reduces Pre-Procedural Anxiety in TEER Patients, But Timing Seems Crucial

NCT07140562Not ApplicableRecruiting

Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation

NCT07043465Not ApplicableCompletedPrimary

Ambulant Monitoring to Detect Hemodynamic and Electrical Impact of Severe Tricuspid Valve Regurgitation

NCT06877520Not ApplicableRecruitingPrimary

Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment

NCT06902922Not Yet RecruitingPrimary

Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastrointestinal Function

NCT06814574Recruiting

Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement

Showing all 17 trials

Research Network

Activity Timeline